Literature DB >> 18543294

Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique.

Xingwang Zhang1, Danni Wu, Jie Lai, Yi Lu, Zongning Yin, Wei Wu.   

Abstract

This work was aimed at investigating the feasibility of fluid-bed coating as a new method to prepare cyclodextrin inclusion complex. The inclusion complex of the model drug piroxicam (PIX) and 2-hydroxypropyl-beta-cyclodextrin (HPCD) in aqueous ethanol solution was sprayed and deposited onto the surface of the pellet substrate upon removal of the solvent. The coating process was fluent with high coating efficiency. Scanning electron microscopy revealed a coarse pellet surface, and a loosely packed coating structure. Significantly enhanced dissolution, over 90% at 5 min, was observed at stoichiometric PIX/HPCD molar ratio (1/1) and at a ratio with excessive HPCD (1/2). Differential scanning calorimetry and powder X-ray diffractometry confirmed absence of crystallinity of PIX at PIX/HPCD molar ratio of 1/1 and 1/2. Fourier transform-infrared spectrometry and Raman spectrometry revealed interaction between PIX and HPCD adding evidence on inclusion of PIX moieties into HPCD cavities. Solid-state (13)C NMR spectrometry indicated possible inclusion of PIX through the pyridine ring. It is concluded that fluid-bed coating has potential to be used as a new technique to prepare cyclodextrin inclusion complex.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18543294     DOI: 10.1002/jps.21453

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.

Authors:  Xingwang Zhang; Tianpeng Zhang; Yali Lan; Baojian Wu; Zhihai Shi
Journal:  AAPS PharmSciTech       Date:  2015-07-18       Impact factor: 3.246

2.  Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility.

Authors:  Yang Lei; Yi Lu; Jianping Qi; Sufang Nie; Fuqiang Hu; Weisan Pan; Wei Wu
Journal:  Int J Nanomedicine       Date:  2011-04-19

3.  Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling.

Authors:  Yi Lu; Tao Guo; Jianping Qi; Jiwen Zhang; Wei Wu
Journal:  AAPS PharmSciTech       Date:  2012-09-12       Impact factor: 3.246

4.  Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation.

Authors:  Xingwang Zhang; Guijiang Chen; Tianpeng Zhang; Zhiguo Ma; Baojian Wu
Journal:  Int J Nanomedicine       Date:  2014-11-26

5.  Pharmaceutical composition of hydrochlorothiazide:β-cyclo-dextrin: preparation by three different methods, physico-chemical characterization and in vivo diuretic activity evaluation.

Authors:  Maria Arlete Silva Pires; Robson Augusto Souza Dos Santos; Rubén Dario Sinisterra
Journal:  Molecules       Date:  2011-05-27       Impact factor: 4.411

6.  In Vitro and Ex Vivo Evaluation of Tablets Containing Piroxicam-Cyclodextrin Complexes for Buccal Delivery.

Authors:  Eleni Kontogiannidou; Martina Ferrari; Asteria-Danai Deligianni; Nikolaos Bouropoulos; Dimitrios A Andreadis; Milena Sorrenti; Laura Catenacci; Kazem Nazari; Muhammad Sohail Arshad; Ming-Wei Chang; Zeeshan Ahmad; Dimitrios G Fatouros
Journal:  Pharmaceutics       Date:  2019-08-08       Impact factor: 6.321

7.  Bile salt/phospholipid mixed micelle precursor pellets prepared by fluid-bed coating.

Authors:  Fuxia Dong; Yunchang Xie; Jianping Qi; Fuqiang Hu; Yi Lu; Sanming Li; Wei Wu
Journal:  Int J Nanomedicine       Date:  2013-04-26

8.  Nanoemulsions as novel oral carriers of stiripentol: insights into the protective effect and absorption enhancement.

Authors:  Rong Lu; Shan Liu; Qilin Wang; Xia Li
Journal:  Int J Nanomedicine       Date:  2015-07-31

9.  Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents.

Authors:  Sultan Alshehri; Syed Sarim Imam; Afzal Hussain; Mohammad A Altamimi; Nabil K Alruwaili; Fahad Alotaibi; Abdullah Alanazi; Faiyaz Shakeel
Journal:  Drug Deliv       Date:  2020-11-09       Impact factor: 6.419

10.  Electrospun Gelatin Nanocontainers for Enhanced Biopharmaceutical Performance of Piroxicam: In Vivo and In Vitro Investigations.

Authors:  Lin Zhao; Omer Mustapha; Shumaila Shafique; Talha Jamshaid; Fakhar Ud Din; Yasir Mehmood; Khaleeq Anwer; Qurrat Ul Ain Yousafi; Talib Hussain; Ikram Ullah Khan; Muhammad Usman Ghori; Yasser Shahzad; Abid Mehmood Yousaf
Journal:  Int J Nanomedicine       Date:  2020-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.